Search results
Results from the WOW.Com Content Network
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...
Experimental anti-obesity drugs (5 C, 20 P) G. GIP receptor agonists (7 P) GLP-1 receptor agonists (35 P) W. Withdrawn anti-obesity drugs (9 P)
Anti-Obesity Day (AOD) is observed in various parts of the world on November 26, with several healthcare organizations and leading Media primarily in India and the Gulf Cooperation Council (GCC) countries marking the day with activities to highlight how obesity is a public health hazard.
Several anti-obesity medications are currently approved by the FDA for long term use. [ 54 ] [ 55 ] [ 56 ] Semaglutide (Wegovy) is currently approved by the FDA for long-term use, being associated with a 6-12% loss in body weight compared to placebo.
Obesity is a major cause of disability and is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis. [2] [12] [13] Obesity has individual, socioeconomic, and environmental causes.
Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity. [4] [6] It contains naltrexone, an opioid antagonist, and bupropion, an aminoketone atypical antidepressant. [4]
This page was last edited on 1 December 2023, at 23:34 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Obesity medicine is a field of medicine dedicated to the comprehensive treatment of patients with obesity. Obesity medicine takes into account the multi-factorial etiology of obesity in which behavior, development, environment, epigenetic , genetic , nutrition , physiology , and psychosocial contributors all play a role. [ 1 ]